JPRN-UMIN000032340CompletedPhase 1
A Phase I/II trial of radical carbon-ion radiotherapy using 4 fractions for the patients with low- or intermediate-risk prostate cancer - Radical carbon-ion radiotherapy using 4 fractions for prostate cancer
Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology0 sites60 target enrollmentStarted: May 10, 2018Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- Male
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1) Other therapies except for hormonal therapy 2) Previous radiation therapy to the pelvis 3) Ineligible dose constraints of risk organs 4) Castration resistant prostate cancer 5) Previous TUR-P 6) Active Double cancer 7) Presence of active double cancer
Investigators
Similar Trials
Suspended
Phase 1
4fr.CIRT for high risk-prostate cancer + dose measurementD011471Prostate cancerJPRN-jRCTs032190180Tsuji Hiroshi40
Recruiting
Phase 2
A Phase II Trial of 4 fractions of CIRT for Intermediate-risk Prostate CancerD011471Prostate cancerJPRN-jRCT1032220391Ishikawa Hitoshi212
Completed
Phase 1
A Phase I/II clinical trial of Carbon-ion radiotherapy in 4 fractions over 1 week for patients with renal cell carcinomaRenal cell carcinomaJPRN-UMIN000029469ational Institutes for Quantum Science and Technology10
Recruiting
Phase 1
A phase I/II clinical trial of carbon-ion radiotherapy and concurrent cisplatin chemotherapy for locally advanced adenocarcinoma of the uterine cervixJPRN-UMIN000003585Research center for charged particle therapy, National institute of radiological sciences of Japan32
Completed
Phase 1
A phase I/II clinical trial of carbon-ion radiotherapy in 12 fractions for prostate cancerprostate cancerJPRN-UMIN000003838ational Institute of Radiological Sciences, Network congress of charged particle therapy45